Eledon Pharmaceuticals Inc (ELDN)
4.13
-0.14
(-3.28%)
USD |
NASDAQ |
Nov 14, 16:00
4.03
-0.10
(-2.42%)
After-Hours: 20:00
Eledon Pharmaceuticals Enterprise Value: 171.48M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 171.48M |
| November 12, 2024 | 204.33M |
| November 11, 2024 | 212.70M |
| November 08, 2024 | 204.93M |
| November 07, 2024 | 212.70M |
| November 06, 2024 | 219.27M |
| November 05, 2024 | 214.49M |
| November 04, 2024 | 204.93M |
| November 01, 2024 | 233.01M |
| October 31, 2024 | 194.18M |
| October 30, 2024 | 166.70M |
| October 29, 2024 | 64.96M |
| October 28, 2024 | 55.85M |
| October 25, 2024 | 56.68M |
| October 24, 2024 | 62.89M |
| October 23, 2024 | 60.82M |
| October 22, 2024 | 47.37M |
| October 21, 2024 | 41.78M |
| October 18, 2024 | 39.30M |
| October 17, 2024 | 32.68M |
| October 16, 2024 | 37.64M |
| October 15, 2024 | 38.47M |
| October 14, 2024 | 30.19M |
| October 11, 2024 | 27.30M |
| October 10, 2024 | 27.71M |
| Date | Value |
|---|---|
| October 09, 2024 | 25.64M |
| October 08, 2024 | 24.81M |
| October 07, 2024 | 24.81M |
| October 04, 2024 | 24.81M |
| October 03, 2024 | 21.92M |
| October 02, 2024 | 20.26M |
| October 01, 2024 | 17.36M |
| September 30, 2024 | 18.94M |
| September 27, 2024 | 15.13M |
| September 26, 2024 | 17.12M |
| September 25, 2024 | 15.13M |
| September 24, 2024 | 16.32M |
| September 23, 2024 | 17.51M |
| September 20, 2024 | 21.48M |
| September 19, 2024 | 14.74M |
| September 18, 2024 | 15.53M |
| September 17, 2024 | 16.32M |
| September 16, 2024 | 19.10M |
| September 13, 2024 | 21.48M |
| September 12, 2024 | 16.32M |
| September 11, 2024 | 17.91M |
| September 10, 2024 | 21.48M |
| September 09, 2024 | 14.34M |
| September 06, 2024 | 17.12M |
| September 05, 2024 | 18.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-94.63M
Minimum
Dec 24 2020
233.01M
Maximum
Nov 01 2024
-5.253M
Average
-9.213M
Median
Feb 02 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.762M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
| Oragenics Inc | 2.142M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.91M |
| Total Expenses (Quarterly) | 14.50M |
| EPS Diluted (Quarterly) | -1.06 |
| Earnings Yield | -135.1% |